Search research articles
Contact Us
Filters
Showing results (481-490 of 578) with videos related to
Page
of 58
Sort By:
The New England Journal of Medicine
|
December 7, 2021
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer
Philipp Harter, Jalid Sehouli, Ignace Vergote, et al.
Virchows Archiv : an International Journal of Pathology
|
February 19, 2021
ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma
Nicole Concin, Carien L Creutzberg, Ignace Vergote, et al.
The New England Journal of Medicine
|
October 9, 2016
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
Mansoor R Mirza, Bradley J Monk, Jørn Herrstedt, et al.
BMJ (Clinical Research Ed.)
|
August 1, 2020
Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study
Ben Van Calster, Lil Valentin, Wouter Froyman, et al.
The New England Journal of Medicine
|
July 3, 2024
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
Ignace Vergote, Antonio González-Martín, Keiichi Fujiwara, et al.
Carcinogenesis
|
October 4, 2011
Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study
Catherine S Healey, Shahana Ahmed, , et al.
Science Translational Medicine
|
March 20, 2020
Strong vaccine responses during chemotherapy are associated with prolonged cancer survival
Cornelis J M Melief, Marij J P Welters, Ignace Vergote, et al.
Journal of the National Cancer Institute
|
June 20, 2013
L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation
Alain G Zeimet, Daniel Reimer, Monica Huszar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 15, 2023
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
Rachel N Grisham, Ignace Vergote, Susana Banerjee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2023
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial
Jean-Emmanuel Kurtz, Eric Pujade-Lauraine, Ana Oaknin, et al.
Page
of 58
Search research articles
Search
Showing results (481-490 of 578) with videos related to
Sort By:
Page
of 58
The New England Journal of Medicine
|
December 7, 2021
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer
Philipp Harter, Jalid Sehouli, Ignace Vergote, et al.
Virchows Archiv : an International Journal of Pathology
|
February 19, 2021
ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma
Nicole Concin, Carien L Creutzberg, Ignace Vergote, et al.
The New England Journal of Medicine
|
October 9, 2016
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
Mansoor R Mirza, Bradley J Monk, Jørn Herrstedt, et al.
BMJ (Clinical Research Ed.)
|
August 1, 2020
Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study
Ben Van Calster, Lil Valentin, Wouter Froyman, et al.
The New England Journal of Medicine
|
July 3, 2024
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
Ignace Vergote, Antonio González-Martín, Keiichi Fujiwara, et al.
Carcinogenesis
|
October 4, 2011
Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study
Catherine S Healey, Shahana Ahmed, , et al.
Science Translational Medicine
|
March 20, 2020
Strong vaccine responses during chemotherapy are associated with prolonged cancer survival
Cornelis J M Melief, Marij J P Welters, Ignace Vergote, et al.
Journal of the National Cancer Institute
|
June 20, 2013
L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation
Alain G Zeimet, Daniel Reimer, Monica Huszar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 15, 2023
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
Rachel N Grisham, Ignace Vergote, Susana Banerjee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2023
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial
Jean-Emmanuel Kurtz, Eric Pujade-Lauraine, Ana Oaknin, et al.
Page
of 58